Showing results (91-100 of 5,040) with videos related to
Sort By:
Pageof 504
Multiple Sclerosis and Related Disorders|May 27, 2019
Illegal cannabis use is common among Danes with multiple sclerosisS Gustavsen, H B Søndergaard, S R Andresen, et al.Multiple Sclerosis and Related Disorders|April 22, 2022
Magnetic resonance imaging criteria at onset to differentiate pediatric multiple sclerosis from acute disseminated encephalomyelitis: A nationwide cohort studyMagnus Spangsberg Boesen, Morten Blinkenberg, Lau Caspar Thygesen, et al.Multiple Sclerosis and Related Disorders|April 22, 2022
Comorbidities as predictors of all-cause emergency department utilization among veterans with multiple sclerosisElizabeth S Gromisch, Aaron P Turner, Steven L Leipertz, et al.Multiple Sclerosis and Related Disorders|April 22, 2022
Pregnancy outcomes of women with multiple sclerosis treated with ocrelizumab in Canada: A descriptive analysis of real-world dataVictor Gitman, Aphrodite Stavropoulos, Victoria Saenz, et al.Multiple Sclerosis and Related Disorders|March 27, 2022
Sociodemographic and clinical characteristics of people with multiple sclerosis and neuro-myelitis optica spectrum disorder in a central northern region of Chile: A prevalence studyKatherine Henríquez, Fernando Molt, Javiera Gajardo, et al.Multiple Sclerosis and Related Disorders|March 26, 2022
Identification of potential key genes and immune infiltration in Multiple sclerosisYang Liu, Yinglian Zhou, Hui Yue, et al.Multiple Sclerosis and Related Disorders|April 24, 2022
Validity and reliability of Korean version of Modified Fatigue Impact Scale (MFIS) for Korean patients with multiple sclerosisYeon Hak Chung, Ansuk Jeong, Byoung Joon Kim, et al.Multiple Sclerosis and Related Disorders|April 14, 2022
Humoral response to SARS-CoV-2 infection and vaccines against COVID-19 in patients with neuromyelitis optica spectrum disorders: Impact of immunosuppressive treatmentVanja Jovicevic, Jovana Ivanovic, Nikola Momcilovic, et al.Multiple Sclerosis and Related Disorders|April 16, 2022
Patient-Specific Out-of-Pocket Cost Communication and Remote Financial Navigation in Patients with Multiple Sclerosis: A Randomized Controlled Feasibility StudyGelareh Sadigh, Debrua Coleman, Neil Lava, et al.Multiple Sclerosis and Related Disorders|April 17, 2022
Hearing loss among patients with multiple sclerosis (PwMS): A systematic review and meta-analysisOmid Mirmosayyeb, Mohammadjavad Naderi, Sina Raeisi, et al.Pageof 504